-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c_surveillance.pdf
December 01, 2015 - Psychosocial assessment and monitoring in the new era of
non-interferon-alpha hepatitis C virus treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_surveillance.pdf
December 01, 2015 - Psychosocial assessment and monitoring in the new era of
non-interferon-alpha hepatitis C virus treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism_disposition-comments.pdf
November 01, 2010 - Equating
this with treatment fidelity monitoring, which is
important and practicable, doesn't seem … Is monitoring fidelity
sufficient when it is low? Doesn't seem like it
should be.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-rapid-response-patient-family-engagement.pdf
October 01, 2023 - Making Healthcare Safer IV_Rapid Response: Patient and Family Engagement
Making Healthcare Safer IV
Patient and Family Engagement
Rapid Response
Main Points
• Patient and family engagement as a patient safety practice (PSP) is an emerging area with
few studies evaluating the effectiveness of such enga…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-202-thermoplasty-comments.pdf
December 14, 2017 - Consequently we graded the evidence in
this situation as insufficient.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-radiation_technical-brief.pdf
November 01, 2009 - Effective Health Care
Technical Brief
Number 1
Particle Beam Radiation Therapies
for Cancer
This report is based on research conducted by the Tufts Medical Center Evidence-based Practice
Center (EPC) under contract to the Agency for Healthcare R…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation_executive.pdf
June 01, 2013 - Some
investigators have relied on periodic Holter monitoring,
but it remains unclear whether this is
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_surveillance.pdf
August 01, 2012 - CER # 23:
Effectiveness of Recombinant Human Growth Hormone (rhGH)
in the Treatment of Patients with Cystic Fibrosis
Original release date:
October 2010
Surveillance Report 1st Assessment: November, 2011
Surveillance Report 2nd Assessment: August 2012
Key Findings 1st Assessment:
• All conclusions for KQ…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/children-special-needs-transition_disposition-comments.pdf
June 17, 2014 - leads to confusion ... the reader does not know if the text is referring to
"transition care" or to a situation
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-adult-treatment_disposition-comments.pdf
April 03, 2013 - Disposition of Comments for Psychological Treatments and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD)
Comparative Effectiveness Research Review Disposition of Comments Report
Research Review Title: Psychological Treatments and Pharmacological Treatments for Adults
With Pos…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/machine-learning-tools-white-paper.pdf
December 01, 2024 - This might replicate a situation in which the
tool is being used to automatically screen update searches
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children-surveillance-150120.pdf
October 01, 2014 - Patients should receive regular monitoring of weight, fasting blood glucose, and lipid profile at the
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/wireless-motility-capsule_disposition-comments.pdf
May 20, 2013 - Wireless Capsule Motility: Comparison of
the SmartPill GI Monitoring System with Scintigraphy for
Measuring
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0_0.pdf
March 01, 2022 - control groups), intervention factors (e.g., dose and duration of therapy, intensity
and frequency of monitoring
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
May 01, 2022 - control groups), intervention factors (e.g., dose and duration of therapy, intensity
and frequency of monitoring
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/decision-models-guidance_methods.pdf
October 01, 2016 - Guidance for the Conduct and Reporting of Modeling and Simulation Studies in the Context of Health Technology Assessment
Methods Guide
for Comparative Effectiveness Reviews
Guidance for the Conduct and Reporting of Modeling
and Simulation Studies in the Context of Health
Technology Assessment
Th…